Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Boston Medical Technologies: Private placement valued at $22.6 mil. brings to $38 mil. the total raised by the start-up since July 1998. Funds will be used for expansion efforts to meet "growing demand" for the Wakefield, Massachusetts firm's Anscore system for measuring diabetic patients' heart rate variability during physician office visits, BMT says. The non-invasive device was initially cleared via 510(k) in June 1999, with subsequent clearances in August 2000 and April 2001 expanding system parameters. "Extensive published clinical data reports that heart rate variability testing can be used as an indicator of autonomic nervous system dysfunction - a deadly but initially asymptomatic condition prevalent in people with diabetes," BMT explains. Prism Venture Partners led the third-round financing...